We recently reported on the activity of cationic amphiphiles in inhibiting TLR4 activation and subsequent production of inflammatory cytokines in cells and in animal models Starting from the assumption that opportunely designed cationic amphiphiles can behave as CD14/MD-2 ligands and therefore modulate the TLR4 signaling, we present here a panel of amphiphilic guanidinocalixarenes whose structure was computationally optimized to dock into MD-2 and CD14 binding sites. Some of these calixarenes were active in inhibiting, in a dose- dependent way, the LPS-stimulated TLR4 activation and TLR4-dependent cytokine production in human and mouse cells. Moreover, guanidinocalixarenes also inhibited TLR4 signaling when TLR4 was activated by a non-LPS stimulus, the plant lectin PHA. While the activity of guanidinocalixarenes in inhibiting LPS toxic action has previously been related to their capacity to bind LPS, we suggest a direct antagonist effect of calixarenes on TLR4/MD-2 dimerization, pointing at the calixarene moiety as a potential scaffold for the development of new TLR4- directed therapeutics.

Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling / Sestito, Stefania E.; Facchini, Fabio A.; Morbioli, Ilaria; Billod, Jean Marc; Martin Santamaria, Sonsoles; Casnati, Alessandro; Sansone, Francesco; Peri, Francesco. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 60(2017), pp. 4882-4892. [10.1021/acs.jmedchem.7b00095]

Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling

MORBIOLI, Ilaria;CASNATI, Alessandro;SANSONE, Francesco;
2017

Abstract

We recently reported on the activity of cationic amphiphiles in inhibiting TLR4 activation and subsequent production of inflammatory cytokines in cells and in animal models Starting from the assumption that opportunely designed cationic amphiphiles can behave as CD14/MD-2 ligands and therefore modulate the TLR4 signaling, we present here a panel of amphiphilic guanidinocalixarenes whose structure was computationally optimized to dock into MD-2 and CD14 binding sites. Some of these calixarenes were active in inhibiting, in a dose- dependent way, the LPS-stimulated TLR4 activation and TLR4-dependent cytokine production in human and mouse cells. Moreover, guanidinocalixarenes also inhibited TLR4 signaling when TLR4 was activated by a non-LPS stimulus, the plant lectin PHA. While the activity of guanidinocalixarenes in inhibiting LPS toxic action has previously been related to their capacity to bind LPS, we suggest a direct antagonist effect of calixarenes on TLR4/MD-2 dimerization, pointing at the calixarene moiety as a potential scaffold for the development of new TLR4- directed therapeutics.
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling / Sestito, Stefania E.; Facchini, Fabio A.; Morbioli, Ilaria; Billod, Jean Marc; Martin Santamaria, Sonsoles; Casnati, Alessandro; Sansone, Francesco; Peri, Francesco. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 60(2017), pp. 4882-4892. [10.1021/acs.jmedchem.7b00095]
File in questo prodotto:
File Dimensione Formato  
post print JMedChem.pdf

embargo fino al 31/01/2019

Descrizione: Post-Print
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 4.74 MB
Formato Adobe PDF
4.74 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2828626
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 23
social impact